[Financial Results Flash] Cytiva? No, wait: The text is Japanese. The translation would render as: [Financial Results Flash] Sinbio Medinet AnGes Sorejia!!

SymBio Pharmaceuticals announced its earnings after the market close on February 10. For the year ending December 2021, ordinary income (non-consolidated) turned to a profit of 1.0 billion yen (the previous year was a 4.61 billion yen loss), and for the year ending December 2022, the same profit is expected to expand by 74.8% year over year to 1.75 billion yen, indicating that profits will hit record highs for the second consecutive year. In the most recent three months, the October-December quarter (Q4) ordinary income turned to a profit of 580 million yen (the same period last year was a 1.39 billion yen loss), and the operating profit margin on sales improved sharply from -208.2% in the previous year’s quarter to 21.9%.